INO

11.45

0.43% -0.05

Dopo l'orario di chiusura: 11.4217 -0.0283 -0.25%

Inovio Pharmaceuticals Inc (INO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Frazionamento azionario

Precedente Chiudi:

$11.50

Aprire:

$11.39

Volume 24 ore:

191.52K

Capitalizzazione di mercato:

$296.63M

Reddito:

$832.00K

Utile/perdita netta:

$-135.12M

Rapporto P/E:

-17.62

EPS:

-0.65

Flusso di cassa netto:

$-124.69M

1 W Prestazione:

+10.41%

1M Prestazione:

-17.51%

6M Prestazione:

+3,043%

1 anno Prestazione:

+1,382%

Intervallo 1D:

$11.14

$11.58

Portata 52W:

$0.324

$14.75

Inovio Pharmaceuticals Inc Stock (INO) Company Profile

Nome

Inovio Pharmaceuticals Inc

Settore

Healthcare (1191)

Industria

Biotechnology (682)

Telefono

267-440-4200

Indirizzo

660 West Germantown Pike, Suite 110, Plymouth Meeting, PA

Dipendente

278

Cinguettio

@inoviopharma

Prossima data di guadagno

2024-05-21

Ultimi documenti SEC

INO's Discussions on Twitter

Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-11-09	Downgrade	Maxim Group	Buy → Hold
2022-11-01	Downgrade	BofA Securities	Neutral → Underperform
2022-07-19	Ripresa	RBC Capital Mkts	Sector Perform
2022-05-11	Downgrade	Oppenheimer	Outperform → Perform
2022-01-21	Aggiornamento	BofA Securities	Underperform → Neutral
2021-12-29	Ripresa	Jefferies	Hold
2021-09-10	Downgrade	BofA Securities	Neutral → Underperform
2021-06-24	Iniziato	Jefferies	Hold
2021-03-23	Iniziato	BofA Securities	Neutral
2021-02-12	Iniziato	Oppenheimer	Outperform
2020-11-17	Downgrade	ROTH Capital	Neutral → Sell
2020-11-10	Aggiornamento	ROTH Capital	Sell → Neutral
2020-09-28	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2020-09-28	Aggiornamento	Maxim Group	Hold → Buy
2020-07-01	Downgrade	Maxim Group	Buy → Hold
2020-07-01	Downgrade	ROTH Capital	Neutral → Sell
2020-06-29	Downgrade	H.C. Wainwright	Buy → Neutral
2020-06-26	Downgrade	Stifel	Buy → Hold
2020-05-21	Iniziato	The Benchmark Company	Buy
2020-04-30	Downgrade	ROTH Capital	Buy → Neutral
2020-03-13	Downgrade	Piper Sandler	Overweight → Neutral
2020-03-13	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2019-12-19	Iniziato	ROTH Capital	Buy
2018-02-15	Reiterato	Maxim Group	Buy
2017-10-18	Iniziato	RBC Capital Mkts	Outperform
2017-09-06	Iniziato	Citigroup	Buy
2017-06-08	Aggiornamento	Piper Jaffray	Neutral → Overweight
2017-05-24	Reiterato	Maxim Group	Buy
2017-03-16	Aggiornamento	Maxim Group	Hold → Buy
2017-03-16	Downgrade	Piper Jaffray	Overweight → Neutral

Mostra tutto

Inovio Pharmaceuticals Inc Borsa (INO) Ultime notizie

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket

Benzinga

Live Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Benzinga

Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?

Zacks Investment Research

Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript

The Motley Fool

Wall Street Breakfast Podcast: Bitcoin Surges Past $65K; Nikkei Tops 40K

Seeking Alpha

Inovio Pharmaceuticals Inc Azioni (INO) Dati Finanziari

Inovio Pharmaceuticals Inc (INO) Reddito 2024

INO ha riportato un ricavo (TTM) di $832.00 mille per il trimestre terminato il 2023-12-31, un -91.89% declino anno su anno.

Inovio Pharmaceuticals Inc (INO) Reddito netto 2024

INO l'utile netto (TTM) è stato di -$135.12 milioni per il trimestre terminato il 2023-12-31, un +51.71% aumento anno su anno.

Inovio Pharmaceuticals Inc (INO) Flusso di cassa 2024

INO ha registrato un flusso di cassa disponibile (TTM) di -$124.69 milioni per il trimestre conclusosi con 2023-12-31, un +42.59% aumento anno su anno.